Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (672)	3/16/2001 8:15:38 PM
From: Nikole Wollerstein	Read Replies (1) \| Respond to of 3044

I joined you today at 23 1/2

To: scaram(o)uche who wrote (672)	3/30/2001 8:22:19 AM
From: scaram(o)uche	Respond to of 3044

cool......... Friday March 30, 7:59 am Eastern Time Press Release SOURCE: Millennium Pharmaceuticals, Inc Millennium Pharmaceuticals Announces Webcast of Third Annual Analyst and Investor Day Presentations CAMBRIDGE, Mass., March 30 /PRNewswire/ --Millennium Pharmaceuticals, Inc (Nasdaq: MLNM - news) announced today that its presentations at the Company's Third Annual Analyst and Investor Day will be webcast via the investor relations section of its website at www.millennium.com. (Photo: newscom.com ) Millennium senior management will provide an overview of the company, including its science and technology platform and downstream drug development initiatives. The presentations will be delivered beginning at 8:45 a.m. on Wednesday, April 4, from the Royal Sonesta Hotel in Cambridge. Millennium, a leading biopharmaceutical company, applies its comprehensive and integrated science and technology platform for the discovery and development of breakthrough therapeutic and predictive medicine products, with a goal of delivering personalized medicine. Through the industrialization of this gene-to-patient platform, Millennium is also striving to accelerate the process of drug discovery and development. Headquartered in Cambridge, Massachusetts, Millennium currently employs more than 1,300 people. Contact: Gina Brazier (investor relations) (617) 551-3611 Maureen Suda (media relations) (617) 551-2959 Millennium Pharmaceuticals, Inc. SOURCE: Millennium Pharmaceuticals, Inc